JPH0144172B2 - - Google Patents

Info

Publication number
JPH0144172B2
JPH0144172B2 JP56206331A JP20633181A JPH0144172B2 JP H0144172 B2 JPH0144172 B2 JP H0144172B2 JP 56206331 A JP56206331 A JP 56206331A JP 20633181 A JP20633181 A JP 20633181A JP H0144172 B2 JPH0144172 B2 JP H0144172B2
Authority
JP
Japan
Prior art keywords
water
rapidly
triacetin
prostaglandin
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56206331A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57134418A (en
Inventor
Haiman Yarukosukii Samyueru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of JPS57134418A publication Critical patent/JPS57134418A/ja
Publication of JPH0144172B2 publication Critical patent/JPH0144172B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP56206331A 1980-12-29 1981-12-22 Triacetin ethanol pge compositions Granted JPS57134418A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/220,599 US4301175A (en) 1980-12-29 1980-12-29 E-Type prostaglandin compositions

Publications (2)

Publication Number Publication Date
JPS57134418A JPS57134418A (en) 1982-08-19
JPH0144172B2 true JPH0144172B2 (OSRAM) 1989-09-26

Family

ID=22824168

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56206331A Granted JPS57134418A (en) 1980-12-29 1981-12-22 Triacetin ethanol pge compositions

Country Status (4)

Country Link
US (1) US4301175A (OSRAM)
EP (1) EP0055593B1 (OSRAM)
JP (1) JPS57134418A (OSRAM)
DE (1) DE3165798D1 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920007569B1 (ko) * 1984-11-30 1992-09-07 쥬우가이 세이야꾸 가부시끼가이샤 프로스타글란딘 e 유도체의 안정한 제제의 제조방법
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
DE69312947T2 (de) * 1992-09-21 1998-01-08 Pharmacia & Upjohn Company Kal Proteinhaftige arzneimittel mit verzögerter wirkstoffabgabe
BRPI0814115B8 (pt) * 2007-07-19 2021-05-25 R Tech Ueno Ltd composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto
EE05864B1 (et) * 2021-12-22 2024-02-15 Aktsiaselts Kevelt 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5729463B2 (OSRAM) * 1973-12-07 1982-06-23
US3966962A (en) * 1975-03-27 1976-06-29 The Upjohn Company Triacetin solutions of PGE-type compounds
JPS5814430B2 (ja) * 1977-04-14 1983-03-18 東レ株式会社 プロスタグランジンｅ類安定化組成物
US4250325A (en) * 1978-12-14 1981-02-10 American Cyanamid Company Novel 15-deoxy-16-ethynyl and -16-(1-propynyl)-1-carboxy and 1-carbinol prostaglandins of the A, D, E and F series
US4211793A (en) * 1979-03-19 1980-07-08 American Cyanamid Company Triethyl citrate solutions of PGE-type compounds

Also Published As

Publication number Publication date
EP0055593A2 (en) 1982-07-07
JPS57134418A (en) 1982-08-19
DE3165798D1 (de) 1984-10-04
US4301175A (en) 1981-11-17
EP0055593B1 (en) 1984-08-29
EP0055593A3 (en) 1982-11-03

Similar Documents

Publication Publication Date Title
US4358603A (en) Acetal stabilized prostaglandin compositions
JP4311369B2 (ja) ４，５−エポキシモルヒナン誘導体を含有する安定な医薬品組成物
FR2670487A1 (fr) Nouveau sel de 3-[2-dimethylamino)ethyl-]-n-methyl-1h-indole-5-methanesulfonamide, sa preparation et son utilisation comme medicament.
JP2005225877A (ja) 末梢血管疾患治療のための９−デオキシ−２’，９−α−メタノ−３−オキサ−４，５，６−トリノール−３，７−（１’，３’−インターフェニレン）−１３，１４−ジヒドロ−プロスタグランジンＦ１の使用
KR100841893B1 (ko) 프레가발린 조성물
US5491171A (en) Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration
HU207220B (en) Process for producing pharmaceutical composition for diminishing enhanced pressure of the pulmonary circulation
FR2584405A1 (fr) Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation
US4301175A (en) E-Type prostaglandin compositions
RU2363462C2 (ru) Фармацевтическая композиция, содержащая 5-метил-2-(2′-хлор-6′-фторанилин)фенилуксусную кислоту
WO2025041166A1 (en) Stable oral liquid formulations containing metoprolol or salts thereof
JPS62501561A (ja) ９−ハロゲンプロスタグランジン−クラスレイト及びその医薬品としての使用
HU179989B (en) Process for preparing pharmacological compositions containing r-/+/-1-/1-phenyl-ethyl/-1h-imidazol-5-carboxylic acid ethyl ester for intravenous administration
US4389414A (en) Prostaglandin compositions
JPH1171269A (ja) 経口液体医薬製剤
NL8101987A (nl) De verbinding 4-amino-1-beta-d-ribofuranosyl-1h-imidazo/4.5-c/-pyridine of een farmaceutisch aanvaardbaar zuuradditiezout daarvan; farmaceutisch preparaat.
JPS6140647B2 (OSRAM)
JPS60158149A (ja) 炎症抑制作用を有する１，４‐ナフトキノン誘導体
US2799617A (en) Piperazine adipate compositions and treatment of helminth infections therewith
US3138529A (en) Tetracycline antibiotic compositions for oral use
JP2522940B2 (ja) Ｓ−ラクトイルグルタチオンおよび／またはその塩を有効成分とする医薬
JPS6334123B2 (OSRAM)
JPH0539226A (ja) サイトメガロウイルス感染症用薬剤
JP2004269363A (ja) アセトアミノフェンを含有する安定な水性医薬組成物
JP2885668B2 (ja) テプレノン製剤